Effect of carvedilol against myocardial injury due to ischemia-reperfusion of the brain in rats

Exp Mol Pathol. 2015 Jun;98(3):558-62. doi: 10.1016/j.yexmp.2015.04.001. Epub 2015 Apr 11.

Abstract

We have previously reported the mechanism behind the myocardial injury and the activation of autonomic nervous system during the ischemia-reperfusion (IR) of the rat brain. This study was planned to investigate the effect of carvedilol, a β-blocker, in improving the myocardial injury caused by IR of the rat brain. We have used a whole cerebral IR model in rats by clamping both the right and left common carotid arteries. Rats were divided into five groups; Sham surgery group (Group-Sham), carvedilol treatment before ischemia group (Group-Is+C), vehicle control group (Group-Is+V), carvedilol treatment before reperfusion group (Group-Re+C) and the vehicle control group (Group-Re+V). We have measured the blood pressure and heart rate via a catheter, myocardial tissue β1-adrenaline receptor (β1-AR) levels, phosphor-p38 mitogen-activated protein kinase (p-p38 MAPK) signaling factor, malondialdehyde (MDA), and apoptosis (TUNEL assay and expression of caspase-7 protein). The results indicated that the increased expressions of β1-AR, p-p38 MAPK, caspase-7, apoptotic cells and MDA level in the myocardial tissue due to brain ischemia-reperfusion were significantly reduced by carvedilol treatment. From these observations we can suggest that, with the advantage of its antioxidant and β blocking action, carvedilol had played the improvement of myocardial injury in ischemia-reperfusion of the brain.

Keywords: Apoptosis; Brain; Cardiac injury; Carvedilol; Ischemia–reperfusion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Animals
  • Apoptosis
  • Blood Pressure
  • Brain / blood supply*
  • Carbazoles / therapeutic use*
  • Carvedilol
  • Heart / drug effects*
  • Heart / physiopathology
  • Heart Rate
  • Male
  • Malondialdehyde / metabolism
  • Myocardium / metabolism
  • Myocardium / pathology
  • Propanolamines / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic, beta-1 / genetics
  • Receptors, Adrenergic, beta-1 / metabolism
  • Reperfusion Injury / drug therapy*
  • Reperfusion Injury / physiopathology
  • p38 Mitogen-Activated Protein Kinases / genetics
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Adrenergic beta-Antagonists
  • Carbazoles
  • Propanolamines
  • Receptors, Adrenergic, beta-1
  • Carvedilol
  • Malondialdehyde
  • p38 Mitogen-Activated Protein Kinases